TAVI-thick on technology but thin on evidence.
Kunal SarkarPublished in: Indian journal of thoracic and cardiovascular surgery (2018)
Transcatheter aortic valve implantation (TAVI) has emerged as one of the most popularly deployed interventional innovations of recent times. After addressing the inoperable and high-risk patients, it is application is being extended to intermediate and low-risk category. There is some disquiet about the strength of evidence on which the clinical application is based. Durability and pacemaker requirement are also areas of concern. This review highlights the areas of concern on these aspects. There is also a need to address these deficiencies in future trials and also bring updated database reports in the public domain.
Keyphrases
- transcatheter aortic valve implantation
- aortic stenosis
- aortic valve
- ejection fraction
- aortic valve replacement
- transcatheter aortic valve replacement
- end stage renal disease
- healthcare
- newly diagnosed
- adverse drug
- chronic kidney disease
- emergency department
- heart failure
- left ventricular
- current status
- locally advanced
- patient reported outcomes
- coronary artery disease